Comparison between impairment and disability scales in immune‐mediated polyneuropathies
- 23 May 2003
- journal article
- clinical trial
- Published by Wiley in Muscle & Nerve
- Vol. 28 (1) , 93-100
- https://doi.org/10.1002/mus.10410
Abstract
The ability of a scale to detect clinical relevant changes over time, i.e., its “responsiveness,” may help clinicians to choose among valid and reliable measures. Therefore, we investigated the responsiveness' rank ordering (best to worse) of six selected valid and reliable scales, namely the Medical Research Council (MRC)‐sumscore, sensory‐sumscore, grip‐strength (Vigorimeter), nine‐hole peg, ten‐meters walking, and a disability‐sumscore, in immune‐mediated polyneuropathies. Patients with newly diagnosed Guillain–Barré syndrome (n = 7) or chronic inflammatory demyelinating polyneuropathy (n = 13) were examined over 52 weeks. Responsiveness of each scale was measured using different methods (effect‐size, standardized response mean score, Wilcoxon matched‐pairs signed‐rank, and a newly devised Schmitz's distribution‐free responsiveness score), and the obtained scores in each method were plotted against the follow‐up period, thus allowing area‐under‐the‐curve calculations (higher area‐under‐the‐curve indicating better responsiveness). Also, longitudinal correlations were performed between the scales' values and patients' own clinical judgments (deteriorated, unchanged, improved) (higher correlation = better responsiveness). A consistent rank ordering was observed in each technique with the disability‐sumscore, MRC‐sumscore, and Vigorimeter being among the best responsive scales. Hence, the primary use of these measures is suggested in studies of immune‐mediated polyneuropathies. Muscle Nerve 28: 93–100, 2003Keywords
This publication has 19 references indexed in Scilit:
- Measuring change over time: Assessing the usefulness of evaluative instrumentsPublished by Elsevier ,2004
- Connecting impairment, disability, and handicap in immune mediated polyneuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Assessing the minimal important difference in symptoms: A comparison of two techniquesPublished by Elsevier ,1996
- Evaluating neurological outcome measures: the bare essentials.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Measuring relevant change: an emerging challenge in rheumatologic clinical trialsArthritis & Rheumatism, 1995
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- Comparisons of Five Health Status Instruments for Orthopedic EvaluationMedical Care, 1990
- Effect Sizes for Interpreting Changes in Health StatusMedical Care, 1989
- Comparative measurement efficiency and sensitivity of five health status instruments for arthritis researchArthritis & Rheumatism, 1985